نوع مقاله : مقاله پژوهشی

نویسندگان

1 دانشیار علوم تشریحی دامپزشکی، دانشکده دامپزشکی، دانشگاه شهرکرد، شهرکرد، ایران

2 دانشجوی دکترای دامپزشکی، دانشکده‌ دامپزشکی، دانشگاه شهرکرد، شهرکرد، ایران

چکیده

زمینه و هدف  هدف از پژوهش حاضر، ارزیابی استریولوژیک تأثیر حفاظتی پانکراتین بر تغییرات مورفولوژیک ایجاد شده در ساختارهای کلیوی موش به‌دنبال تیمار با ال- آرژینین بود.
مواد و روش‌هابرای انجام تحقیق، ۵۰ موش سوری نر بالغ با وزن 2±30 گرم به ۵ گروه (مساوی) دسته‌بندی شدند. در گروه کنترل، هیچ‌گونه تجویزی صورت نگرفت. گروه‌های القای پانکراتیت، 2 دوز 300 و 400 میلی‌گرم در 100 گرم وزن بدن ال- آرژینین دریافت کردند. به گروه‌های القای پانکراتیت با 2 دوز متفاوت، داروی درمانی 5/3 واحد لیپاز- پانکراتین تجویز گردید. تمام تیمارها به‌مدت 3 روز متوالی یک‌بار در روز، محلول ال- آرژینین دریافت کرده و 72 ساعت بعد، محلول لیپاز- پانکراتین به مدت 20 روز به گروه‌های پانکراتیت تجویز گردید.
یافته‌ها نتایج نشان داد که به‌دنبال پانکراتیت تجربی، به‌استثنای حجم بخش مرکزی، کاهش حجم قشر کلیه، حجم لوله‌های پیچیده‌ نزدیک و دور و نیز گلومرول‌ها در گروه‌های تیمار نسبت به گروه کنترل دیده شد. با تجویز لیپاز- پانکراتین همراه با ال-آرژینین، مقادیر میانگین حجم فاکتورهای بخش قشری، لوله‌های پیچیده‌ نزدیک و گلومرول‌ها به گروه کنترل نزدیک شده بود.
نتیجه‌گیری براساس بررسی نهایی یافته‌ها، محلول لیپاز- پانکراتین می‌تواند تا حدی در کاهش تأثیرات پانکراتیت القا شده توسط دوز بالای ال- آرژینین مؤثر باشد.

کلیدواژه‌ها

موضوعات

عنوان مقاله [English]

Stereological Study of the renal structures volume in L-arginine-induced pancreatitis and therapeutically effect of pancreatin

نویسندگان [English]

  • Rahmat allah Fatahian dehkordi 1
  • Mohammad Javad Yazdanpanah 2
  • Reza Khetvan 2

1 Associate professor, Department of Basic Sciences, Faculty of Veterinary Medicine, University of Shahrekord, Shahrekord, Iran

2 Student of veterinary medicine, Faculty of Veterinary Medicine, University of Shahrekord, Shahrekord, Iran

چکیده [English]

Introduction: The aim of this study was to stereological evaluate of the protective effect of pancreatin on morphological changes in mice kidney after treatment with L-arginine .
Materials and Methods: To conduct research, 50 adult male rats weighing 30±2 gr were divided into 5 groups (equal). In the control group, no administration was made. The pancreatitis induction groups received 2 doses of 300 and 400 mg/100 g body weight of L-arginine. To the induction groups with two different doses, therapeutic drug was prescribed 3.5 pp. of lipase-pancreatin. All treatments were received for 3 consecutive days once a day from L-arginine solution and 72 hours later, a lipase-pancreatin solution was administered to groups of pancreatitis for 20 days .
Results: The results showed that due to experimental pancreatitis, except for medulla volume, decreasing volume of renal cortex, proximal and distal convoluted tubules, and glomeruli was observed in the treated groups compared to the control group. By the administration of pancreatin lipase along with L-arginine, mean volume values of factors such as mean volume of renal cortex, proximal convoluted tubules and glomeruli, have gotten closed to the control group .
Conclusion: According to a final review of the findings, lipasepancreatin solution may be partially effective in mitigating the effects of pancreatitis induced by high doses of L-arginine 

کلیدواژه‌ها [English]

  • Stereology
  • L-Arginine
  • Pancreatitis
  • Convoluted Tubules
  • Mice
[1]. Nøjgaard C, Becker U, Matzen P, Andersen JR, Holst C, Bendtsen F. Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course. Pancreas. 2011;40(8):1195-200.
[2]. Lunova M, Zizer E, Kucukoglu O, Schwarz C, Dillmann WH, Wagner M, et al. Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis. PloS One. 2012;7(7):e39972.
[3]. Closa D. Free radicals and acute pancreatitis: much ado about… something. Free Radical Research. 2013;47(11):934-40.
[4]. Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, Pandol SJ. Localized pancreatic NF-κB activation and inflammatory response in taurocholate-induced pancreatitis. American Journal of PhysiologyGastrointestinal and Liver Physiology. 2001;280(6):G1197G208.
[5]. Morris J, Sidney M. Arginine: beyond protein. The American Journal of Clinical Nutrition. 2006;83(2):508S12S.
[6]. Zhou Z, Chen Y, Yu Y, Chen H. Hemorheology and expression of neutrophil adhesion molecules CD18 and CD62L in pancreatic microcirculation of Caerulein induced experimental acute pancreatitis. Chinese Journal of Preventive Medicine. 2002;36(7):528-30.
[7]. Dawra R, Saluja AK. L-arginine-induced experimental acute pancreatitis. Pancreapedia: The Exocrine Pancreas Knowledge Base. 2012.
[8]. Tashiro M, Schäfer C, Yao H, Ernst S, Williams J. Arginine induced acute pancreatitis alters the actin cytoskeleton and increases heat shock protein expression in rat pancreatic acinar cells. Gut. 2001;49(2):241-50.
[9]. Wilmer A. ICU management of severe acute pancreatitis. European Journal of Internal Medicine. 2004;15(5):274-80.
[10]. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Journal of Pancreas. 2003;26(2):122-9.
[11]. Herrera MG, Seller GP, Chaparro MS, Nacle BL. Acute renal failure profile and prognostic value in severe acute pancreatitis. Journal of Medicina clinica. 2000;115(19):7215.
[12]. Boyer A, Chadda K, Salah A, Bonmarchand G. Thrombotic microangiopathy: an atypical cause of acute renal failure in patients with acute pancreatitis. Intensive Care Medicine. 2004;30(6):1235-9.
[13]. Cuthbertson C, Christophi C. Disturbances of the microcirculation in acute pancreatitis. British Journal of Surgery. 2006;93(5):518-30.
[14]. Tzovaras G, Parks RW, Diamond T, Rowlands BJ. Early and long-term results of surgery for severe necrotising pancreatitis. Journal of Digestive surgery. 2004;21(1):41-7.
[15]. Christman JW, Sadikot RT, Blackwell TSJC. The role of nuclear factor-κ B in pulmonary diseases. American Journal of Respiratory Medicine 2000;117(5):1482-7.
[16]. De Waele JJ, Leppäniemi AK. Intra-abdominal hypertension in acute pancreatitis. World Journal of Surgery. 2009;33(6):1128-33.
[17]. Li H, Qian Z, Liu Z, Liu X, Han X, Kang H. Risk factors and outcome of acute renal failure in patients with severe acute pancreatitis. Journal of Critical Care. 2010;25(2):225-9.
[18]. Kodydkova J, Vavrova L, Stankova B, Macasek J, Krechler T, Zak A. Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis. Journal of Pancreas. 2013;42(4):614-21. [19]. De Waele JJ, De Laet I, Kirkpatrick AW, Hoste E. Intraabdominal hypertension and abdominal compartment syndrome. American Journal of Kidney Diseases. 2011;57(1):159-69.
[20]. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, et al. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. II. Recommendations. Intensive Care Medicine. 2007;33(6):951-62.
[21]. Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. Journal of the American Society of Nephrology. 2011;22(4):615-21. [22]. Takeyama Y. Significance of apoptotic cell death in systemic complications with severe acute pancreatitis. Journal of Gastroenterology. 2005;40(1):1-10.
[23]. Thorat V, Reddy N, Bhatia S, Bapaye A, Rajkumar J, Kini D, et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric‐coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis‐a doubleblind, placebo‐controlled study. Journal of Alimentary Pharmacology Therapeutics. 2012;36(5):426-36.
[24]. Whitcomb D, Malecka-Panas E, Lehman G, Vasileva G, Gubergrits N, Caras S, et al. Efficacy and Safety of Pancrelipase Delayed-Release Capsules (Creon®) in Patients With Pancreatic Insufficiency Due to Chronic Pancreatitis or Pancreatic Surgery: 175. American Journal of Gastroenterology. 2009;104:S69-S70.
[25]. Ramesh H, Reddy N, Bhatia S, Rajkumar J, Bapaye A, Kini D, et al. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 entericcoated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013;13(2):133-9.
[26]. Fatahian Dehkordi RA, Habibi A. Stereological and electron microscopic study on the internal organization of the urinary secretory units in three species of birds. Journal of Applied Animal Research. 2015;43(1):118-24.
[27]. White KE. Research into the structure of the kidney glomerulus–making it count. Micron. 2012;43(10):1001-9.
[28]. Mouton PR. Principles and practices of unbiased stereology: an introduction for bioscientists. he Quarterly Review of Biology. 2003;78(4):74.
[29]. Dawra R, Sharif R, Phillips P, Dudeja V, Dhaulakhandi D, Saluja AK. Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2007;292(4):G1009-G18.
[30]. Raff U, Schneider R, Gambaryan S, Seibold S, Reber M, Vornberger N, et al. L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats. Nephron Physiology. 2005;101(3):p39-p50.
[31]. Petejova N, Martinek A. Acute kidney injury following acute pancreatitis: A review. Biomedical Papers of the Medical Faculty of Palacky University in Olomouc. 2013;157(2).
[32]. Piyush M, Sandeep V. Pathophysiology of acute kidney injury in severe acute pancreatitis-an overview Gastroenterology and Hepatology. 2019;10(4):242-5.
[33]. Wajda J, Dumnicka P, Maraj M, Ceranowicz P, Kuźniewski M, Kuśnierz-Cabala B. Potential prognostic markers of acute kidney injury in the early phase of acute pancreatitis. International Journal of Molecular Sciences. 2019;20(15):3714.
[34]. Gu H, Liu A, Ma W, Ni J, Ma C, Zhou X, et al. Berberine hydrochloride mitigates acute pancreatitis by suppressing the TLR4/IκBα/NFκB pathway. Computational life sciences. 2020;13(1):276-85.
[35]. Chen H, Li F, Cheng Y, Sun J. Pathogenic role of neutrophils in evolution of acute pancreatitis in rats. 2001;9(7):776-9.
[36]. Zhang XP, Wang L, Zhou YF, sciences. The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge. Journal of Digestive diseases. 2008;53(2):297-306.
[37]. Zhou X, Mao Q, Chen Y, Shen H. The relationship between pathological characters and changes of oxygen free radicals in rats with acute pancreatitis. World Chinese Journal of Digestology. 2000;8:108-9. [38]. Yan Y, Ai Z, Liu Z, Xu G. Protective effect of angelica injection on acute hemorrhagic necrotizing pancreatitis complicated with renal injury. Digestive Diseases and Sciences. 2000;9:228-30.